|
Open Access- Title
|
Prognostic factors of Invasive Ductal Breast Carcinoma Non Special Type (NST). A Study of 98 cases |
|
|
Author
|
Ioannis Manolis, Georgia Kafiri MD, PhD, Maria Venetikou MD, PhD, Nikolaos Thalassinos MD, PhD, Fragkiski Anthouli-Anagnostopoulou MD, PhD Pathological Anatomy Laboratory, Hippokration General Hospital, Athens, Greece |
|
|
Citation
|
I. Manolis, G. Kafiri, M. Venetikou, N. Thalassinos, F. Anthouli-Anagnostopoulou. Prognostic factors of Invasive Ductal Breast Carcinoma Non Special Type (NST). A Study of 98 cases. Review Clin. Pharmacol. Pharmacokinet. 2023, 37, 2, 53-62. DOI: 10.5281/zenodo.8337644 |
|
|
Publication Date
|
12-09-2023
|
|
|
Full Text Language
|
English |
|
|
article
|
Open access article
DOI: 10.5281/zenodo.8337644 |
|
|
Keywords
|
Prognostic factors, invasive ductal breast carcinoma non special type, tumor stage, lymph nodes stage, tumor grade, HER2, ER receptors, PR receptors, Ki67, comedo necrosis.
|
|
|
Other Terms
|
Clinical Analysis |
|
|
Summary
|
Prognostic factors of histological subtypes in breast cancer, is still not well established, guidelines based on the histological subtype alone. The decisions for therapy are guided mostly independently of the histological subtype and are also guided by biomarkers and tumor stage. We analyzed a special histological subtype, Invasive Ductal Breast Carcinoma Non Special Type and correlated with patient’s age, tumor grade, comedo type necrosis, necrosis, ER and PR receptors, Ki67 expression, HER2 status, pT tumor stage, pN lymph nodes stage, TNM classification and clinical tumor stage, in order to determine the factors which could predict the overall prognosis for this histological type. | |
| References | 1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021; 71: 209–49. doi:https://doi.org/10.3322/ caac.21660. 2. Caldarella A, Buzzoni C, Crocetti E, Bianchi S, Vezzosi V, Apicella P et al. Invasive breast cancer: a significant correlation between histological types and molecular subgroups. J Cancer Res Clin Oncol2013; 139(4):617–623. 3. Dieci MV, Orvieto E, Dominici M, Conte P, Guarneri V Rare breast cancer subtypes: histological, molecular, and clinical peculiarities. Oncologist 2014;19(8):805–813. 4. Han Y, Wang J, Xu B (2020) Clinicopathological characteristics and prognosis of breast cancer with special histological types: a surveillance, epidemiology, and end results database analysis. Breast 54:114–120. 5. WHO (2019) Breast Tumors WHO Classification of Tumors, 5th Edition, 2019. 6. Harbeck, N. & Gnant, M. Breast cancer. Lancet 2017;389:1134–1150. 7. Brierly JD, Gospodarowicz MK, Wittekind C, editors. TNM classification of malignant tumours. 8th ed. Oxford (UK): Wiley Blackwell;2017. 8. Hanrahan EO, Gonzalez-Angulo AM, Giordano SH, et al. Overall survival and cause specific mortality of patients with stage T1a,bN0M0 breast carcinoma. J Clin Oncol.2007; Nov 1;25(31):4952-60. PMID:17971593. 9. American Joint Committee on Cancer. Breast. In: AJCC Cancer Staging Manual. 8th ed. New York, NY:Springer;2017:589.National Comprehensive Cancer Network (NCCN). Practice Guidelines in Oncology: Breast Cancer. Version 8.2021. Accessed at https://www.nccn.org/professionals/physician_gls/pdf/breast.pdf on September 15, 2021. 10. IBMSPSSStatistics 28. Briefguide, U.S., 2020. 11. Pereira H, Pinder SE, Sibbering DM, Galea MH, Elston CW, Blamey RW,Robertson JF, Ellis IO: Pathological prognostic factors in breast cancer.IV: Should you be a typer or a grader? A comparative study of two histological prognostic features in operable breast carcinoma. Histopathology 1995; 27:219-226. 12. Henson DE, Ries L, Freedman LS, Carriaga M: Relationship among outcome, stage of disease, and histologic grade for 22,616 cases of breast cancer. The basis for a prognostic index. Cancer 1991; 68:2142-2149. 13. Rakha EA, El-Sayed ME, Lee AH, Elston CW, Grainge MJ, Hodi Z, Blamey RW, Ellis IO: Prognostic significance of Nottingham histologic grade in invasive breast carcinoma. J Clin Oncol 2008; 26:3153-3158. 14. Hearne BJ, M Teare D., Butt M., Donaldsonet L. Comparison of Nottingham Prognostic Index and Adjuvant Online prognostic tools in young women with breast cancer: review of a single-institution experience. BMJ Open 2015;5: e005576. doi:10.1136/bmjopen-2014-005576. 15. Frkovic-Grazio S, Bracko M: Long term prognostic value of Nottingham histological grade and its components in early (pT1N0M0) breast carcinoma. J Clin Pathol 2002; 55:88-92. 16. Rakha EA, El-Sayed ME, Lee AH, Elston CW, Grainge MJ, Hodi Z, Blamey RW, Ellis IO: Prognostic signifi cance of nottingham histologic grade in invasive breast carcinoma. J Clin Oncol 2008; 26:3153-3158. 17. Li Zhou, Maria Rueda, and Abedalrhman Alkhateeb. Classification of Breast Cancer Nottingham Prognostic Index Using High-Dimensional Embedding and Residual Neural Network. Cancers 2022; 14(4), 934; https://doi.org/10.3390/cancers14040934. 18. Wirapati P, Sotiriou C, Kunkel S, Farmer P, Pradervand S, Haibe-Kains B,Desmedt C, Ignatiadis M, Sengstag T, Schutz F, Goldstein DR, Piccart M, Delorenzi M: Meta-analysis of gene expression profi les in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures. Breast Cancer Res 2008; 10:R. 19. Van Dooijeweert C., van Diest P. J., and Ellis I. O. Grading of invasive breast carcinoma: the way forward. Virchows Archiv 2022;Vol 480 :33–43. 20. Feng Mao, Ru Yao, Li Peng, Jia-Lin Zhao, Zhi-Yong Liang and, Qiang Sun. Predictive clinicopathological characteristics affecting sentinel lymph node metastasis in early breast cancer patients. TCR 2017;Vol. 6 (5). 21. Plichta J. K., Campbell B. M., Mittendorf E. A., and Hwang, S., Anatomy and Breast Cancer Staging: Is It Still Relevant?Surg Oncol Clin N Am 2018; 27: 51–67 |
|
|
Relative Papers
|
||